Novel Targets for Treatment of Pseudomonas aeruginosa Biofilms

Research output: Chapter in Book/Report/Conference proceeding › Book chapter › Communication

Standard

Novel Targets for Treatment of Pseudomonas aeruginosa Biofilms. / Alhede, Morten; Alhede, Maria; Bjarnsholt, Thomas.

Antibiofilm Agents. ed. / Kendra Rumbaugh. Vol. 8 Springer Publishing Company, 2014. p. 257-272 (Springer Series on Biofilms, Vol. 8).

Research output: Chapter in Book/Report/Conference proceeding › Book chapter › Communication

Harvard

Alhede, M, Alhede, M & Bjarnsholt, T 2014, Novel Targets for Treatment of Pseudomonas aeruginosa Biofilms. in K Rumbaugh (ed.), Antibiofilm Agents. vol. 8, Springer Publishing Company, Springer Series on Biofilms, vol. 8, pp. 257-272. <http://link.springer.com/chapter/10.1007/978-3-642-53833-9_12>

APA

Alhede, M., Alhede, M., & Bjarnsholt, T. (2014). Novel Targets for Treatment of Pseudomonas aeruginosa Biofilms. In K. Rumbaugh (Ed.), Antibiofilm Agents (Vol. 8, pp. 257-272). Springer Publishing Company. Springer Series on Biofilms Vol. 8 http://link.springer.com/chapter/10.1007/978-3-642-53833-9_12

Vancouver

Alhede M, Alhede M, Bjarnsholt T. Novel Targets for Treatment of Pseudomonas aeruginosa Biofilms. In Rumbaugh K, editor, Antibiofilm Agents. Vol. 8. Springer Publishing Company. 2014. p. 257-272. (Springer Series on Biofilms, Vol. 8).

Author

Alhede, Morten ; Alhede, Maria ; Bjarnsholt, Thomas. / Novel Targets for Treatment of Pseudomonas aeruginosa Biofilms. Antibiofilm Agents. editor / Kendra Rumbaugh. Vol. 8 Springer Publishing Company, 2014. pp. 257-272 (Springer Series on Biofilms, Vol. 8).

Bibtex

@inbook{dd744e3f6200482781f27e6b6ffa43f6,
title = "Novel Targets for Treatment of Pseudomonas aeruginosa Biofilms",
abstract = "Pseudomonas aeruginosa causes infection in all parts of the human body. The bacterium is naturally resistant to a wide range of antibiotics. In addition to resistance mechanisms such as efflux pumps, the ability to form aggregates, known as biofilm, further reduces Pseudomonas aeruginosa{\textquoteright}s susceptibility to antibiotics. The presence of such biofilms is acknowledged to equal a persistent infection due to their inherent high tolerance to all antimicrobials and immune cells. In this chapter we discuss the mechanisms of biofilm tolerance. The latest biofilm research is reviewed and future treatment strategies such as quorum sensing inhibitors, silver, and antibodies are thoroughly evaluated.",
author = "Morten Alhede and Maria Alhede and Thomas Bjarnsholt",
year = "2014",
month = jan,
day = "1",
language = "English",
isbn = " 978-3-642-53832-2",
volume = "8",
series = "Springer Series on Biofilms",
publisher = "Springer Publishing Company",
pages = "257--272",
editor = "Rumbaugh, {Kendra }",
booktitle = "Antibiofilm Agents",

}

RIS

TY - CHAP

T1 - Novel Targets for Treatment of Pseudomonas aeruginosa Biofilms

AU - Alhede, Morten

AU - Alhede, Maria

AU - Bjarnsholt, Thomas

PY - 2014/1/1

Y1 - 2014/1/1

N2 - Pseudomonas aeruginosa causes infection in all parts of the human body. The bacterium is naturally resistant to a wide range of antibiotics. In addition to resistance mechanisms such as efflux pumps, the ability to form aggregates, known as biofilm, further reduces Pseudomonas aeruginosa’s susceptibility to antibiotics. The presence of such biofilms is acknowledged to equal a persistent infection due to their inherent high tolerance to all antimicrobials and immune cells. In this chapter we discuss the mechanisms of biofilm tolerance. The latest biofilm research is reviewed and future treatment strategies such as quorum sensing inhibitors, silver, and antibodies are thoroughly evaluated.

AB - Pseudomonas aeruginosa causes infection in all parts of the human body. The bacterium is naturally resistant to a wide range of antibiotics. In addition to resistance mechanisms such as efflux pumps, the ability to form aggregates, known as biofilm, further reduces Pseudomonas aeruginosa’s susceptibility to antibiotics. The presence of such biofilms is acknowledged to equal a persistent infection due to their inherent high tolerance to all antimicrobials and immune cells. In this chapter we discuss the mechanisms of biofilm tolerance. The latest biofilm research is reviewed and future treatment strategies such as quorum sensing inhibitors, silver, and antibodies are thoroughly evaluated.

M3 - Book chapter

SN - 978-3-642-53832-2

VL - 8

T3 - Springer Series on Biofilms

SP - 257

EP - 272

BT - Antibiofilm Agents

A2 - Rumbaugh, Kendra

PB - Springer Publishing Company

ER -

ID: 112933602